Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+7.1%
5Y CAGR+16.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+7.1%/yr
Annual compound
5Y CAGR
+16.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$201.49M+0.5%
2024$200.45M+3.9%
2023$193.01M+17.7%
2022$164.04M+28.2%
2021$127.95M+37.8%
2020$92.84M+60.4%
2019$57.88M-